P015 - BODY IMAGE DISSATISFACTION IN PEDIATRIC PATIENTS WITH INFLAMMATORY BOWEL DISEASES
(Room Poster Hall)
19 Jan 18
5:30 PM
-
7:00 PM
Tracks:
Clinical and Research Challenges
Background/Aims: Pediatric patients with inflammatory bowel diseases (IBD) are at increased risk for poor psychosocial outcomes, including body image dissatisfaction (BID). We aimed to determine the prevalence and risk factors for BID in CCFA Partners Kids & Teens cohort. Methods: We performed a cross-sectional study in CCFA Partners Kids & Teens. We included children age 5-18 with IBD. We obtained information on demographics, disease characteristics, and the IMPACT-35. We classified BID as present if “I look awful” or “I look bad” was selected. Disease activity was measured via the pediatric ulcerative colitis activity index (PUCAI) and the short Crohn’s disease activity index (sCDAI). We assessed depression and anxiety through patient reported outcome measurement information system (PROMIS) measures. We performed bivariate analyses to assess associations between BID and characteristics. We then used logistic regression models to evaluate the independent associations between selected risk factors and BID. Results: A total of 664 pediatric patients completed the IMPACT-35, of whom 74 (3.3%) met criteria for BID. Patients with BID were more likely to be female (p<0.001), older (p<0.001) and diagnosed with IBD at an older median age (p<0.001). Those with BID had higher median body mass index percentile (p=0.02), higher rates of active disease (p<0.001), higher rates of current steroid use (p=0.004), and higher rates of depression and anxiety (p<0.001). Female gender (odds ratio [OR] 2.31; 95% confidence interval [CI] 1.22-4.39), depression (OR 4.73; 95% CI 2.41-9.26), and anxiety (OR 5.42; 95% CI 2.48-11.80) were independently associated with BID. Conclusions: Among this sample of pediatric patients with IBD, risk factors for BID include female gender, older age at diagnosis, active disease, current steroid use, higher BMI, and comorbid mood disorder. Interventions to target modifiable risk factors for BID may improve quality of life.